LEUKEMIA, MYELOID, ACUTE
Clinical trials for LEUKEMIA, MYELOID, ACUTE explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, MYELOID, ACUTE trials appear
Sign up with your email to follow new studies for LEUKEMIA, MYELOID, ACUTE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial tests experimental drug for Tough-to-Treat leukemias
Disease control TerminatedThis early-stage study aimed to find a safe dose and check for side effects of an experimental drug called CC-95251. It was tested alone and combined with other cancer drugs in 56 adults with advanced or returning forms of acute myeloid leukemia (AML) and myelodysplastic syndrome…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 31, 2026 12:20 UTC
-
New hope for leukemia patients Who've run out of options
Disease control TerminatedThis study compared an experimental drug called DFP-10917 against standard treatments for adults with acute myeloid leukemia (AML) that has returned or stopped responding after multiple prior treatments. The trial aimed to see if the new drug could achieve longer-lasting complete…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: PHASE3 • Sponsor: Delta-Fly Pharma, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Food fight against superbug: simple diet change may shield vulnerable cancer patients
Prevention TerminatedThis study tested whether a simple diet change—eating more fiber and less fat—could prevent C. difficile infections from coming back in cancer patients. It focused on people with leukemia or lymphoma who had just had their first or second C. diff infection. The trial was small an…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Prevention
Last updated Mar 18, 2026 14:40 UTC